Presented By:
Lauren Mikulski
Senior Director, Product Management Genetic Science Division, Clinical Solutions, Thermo Fisher Scientific
Vijay Singh, PhD
Managing Principal Scientist , Molecular Diagnostics, HealthTrack, Rx
Andrew Brooks, Ph.D.
Professor of Genetics Rutgers University; COO RUCDR Infinite Biologics; CSO Brooks Life Sciences
Webinar:
Applied Biosystems™ TaqPath™ COVID-19 Combo Kit*: A highly sensitive, specific, and robust real-time PCR test
Webinar Abstract:
In late 2019, researchers identified the SARS-CoV-2 pathogen as the virus responsible for COVID-19. The virus spread rapidly throughout the world and was declared a global health concern by the World Health Organization. At the end of January 2020, Thermo Fisher Scientific launched a SARS-CoV-2 pathogen detection assay, which was quickly developed into a multiplex kit containing highly specific assays and controls targeting three different regions of the SARS-CoV-2 genome. The kit was approved for Emergency Use Authorization (EUA) by the United States Food and Drug Administration in March, and has since been used as a central component of other EUA approved protocols.
Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots (www.labroots.com/ms/webinar/t...)
2. Watch the webinar on KZitem or on the LabRoots Website (www.labroots.com/ms/webinar/t...)
3. Click Here to get your PACE credits (Expiration date - July 1, 2022): (www.labroots.com/credit/pace-...)
LabRoots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc
Негізгі бет Ғылым және технология Applied Biosystems™ TaqPath™ COVID-19 Combo Kit*: A highly sensitive, specific, and robust...
Пікірлер